Online citations, reference lists, and bibliographies.

New Technologies For Application To Veterinary Therapeutics.

J. Riviere
Published 2010 · Engineering, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The purpose of this contribution is to review new technologies and make an educated prediction as to how they will impact veterinary pharmacology over the coming decades. By examining past developments, it becomes evident that change is incremental and predictable unless either a transforming discovery or a change in societal behaviour occurs. In the last century, both discoveries and behaviours have dramatically changed medicine, pharmacology and therapeutics. In this chapter, the potential effects of six transforming technologies on veterinary therapeutics are examined: continued advances in computer technology, microfluidics, nanotechnology, high-throughput screening, control and targeted drug delivery and pharmacogenomics. These should lead to the more efficacious and safer use of existing medicants, and the development of novel drugs across most therapeutic classes through increases in our knowledge base, as well as more efficient drug development. Although this growth in technology portends major advances over the next few decades, economic and regulatory constraints must still be overcome for these new drugs or therapeutic approaches to become common practise.
This paper references
The Human-Animal Bond and Grief
L. Lagoni (1994)
10.1016/j.yrtph.2008.05.003
Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model.
J. Buur (2008)
Pharmacometrics : the science of quantitative pharmacology
E. Ette (2007)
10.1126/SCIENCE.1069492
Systems Biology: A Brief Overview
H. Kitano (2002)
10.1073/PNAS.95.1.334
Large-scale temporal gene expression mapping of central nervous system development.
X. Wen (1998)
10.1016/S1056-8719(00)00111-8
Genomics and proteomics: the new millennium of drug discovery and development.
M. J. Cunningham (2000)
10.1021/tx7002118
Quantification of chemical mixture interactions modulating dermal absorption using a multiple membrane fiber array.
R. Baynes (2008)
10.1016/S0168-3659(01)00331-5
PEG drugs: an overview.
R. Greenwald (2001)
10.1128/AAC.01355-05
Use of Probabilistic Modeling within a Physiologically Based Pharmacokinetic Model To Predict Sulfamethazine Residue Withdrawal Times in Edible Tissues in Swine
J. Buur (2006)
10.1021/nl803481q
Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model.
H. A. Lee (2009)
Comprar Nanotoxicology: Characterization, Dosing and Health Effects | Nancy A. Monteiro-Riviere | 9781420045147 | Informa Healthcare
N. A. Monteiro-Riviere (2007)
10.3109/9781420045154
Nanotoxicology : characterization, dosing and health effects
N. Monteiro-Riviere (2007)
10.1016/J.TAAP.2007.03.026
An experimentally based approach for predicting skin permeability of chemicals and drugs using a membrane-coated fiber array.
Xin-Rui Xia (2007)
10.1016/0925-4005(90)80209-I
Miniaturized total chemical analysis systems: A novel concept for chemical sensing
A. Manz (1990)
10.1021/NL070375J
Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators.
Jessica P. Ryman-Rasmussen (2007)
10.1002/9780470571224.pse065
Physiologically Based Pharmacokinetic Modeling
H. Clewell (2010)
10.1211/jpp.59.2.0004
Process analytical applications of Raman spectroscopy
J. Rantanen (2007)
10.1002/0471478768
Physiologically Based Pharmacokinetic Modeling : Science and Applications
M. Andersen (2005)
10.1039/B511718F
Microfluidic arrays for logarithmically perfused embryonic stem cell culture.
Lily Nari Kim (2006)
10.1126/SCIENCE.1063273
Drugs on Target
R. Langer (2001)
10.1039/B403091E
Patterned cell culture inside microfluidic devices.
S. W. Rhee (2005)
10.1126/SCIENCE.316.5831.1553A
Initiative Aims to Merge Animal and Human Health Science to Benefit Both
M. Enserink (2007)
10.1053/TVJL.2001.0579
Pharmacological treatment in behavioural medicine.
S. Mayhew (2001)
Science and applications
Sigarch (1989)
10.1016/J.TVJL.2007.06.022
The future of veterinary therapeutics: a glimpse towards 2030.
J. Riviere (2007)
10.1016/J.IJFOODMICRO.2004.02.005
Scientific Criteria to Ensure Safe Food: Institute of Medicine, Natural Research Council of the National Academies. The National Academy Press, Washington D.C.; www.nap.edu; xxi+401 pages; soft cover, $35.95; ISBN 0-309-08928-X (hard cover)
N. Skovgaard (2004)
10.1038/nnano.2006.180
Towards an in vivo biologically inspired nanofactory.
P. LeDuc (2007)
10.1023/A:1012129801406
Electrically-Assisted Transdermal Drug Delivery
J. Riviere (2004)
10.1111/J.1365-2885.2007.00864.X
Dirlotapide: a review of its properties and role in the management of obesity in dogs.
J. Wren (2007)
10.2174/138920006777697963
Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening.
Y. Hsieh (2006)
Nanotechnology For Dummies
Earl Boysen (2005)
10.1126/SCIENCE.1990438
Light-directed, spatially addressable parallel chemical synthesis.
S. P. Fodor (1991)
10.1111/J.1365-2885.2004.00607.X
Therapeutic implications of the MDR-1 gene.
K. Mealey (2004)
10.1046/J.1365-2885.2003.00451.X
A physiologically based pharmacokinetic model for oxytetracycline residues in sheep.
A. Craigmill (2003)
The environmental food crisis : the environment's role in averting future food crises
C. Nellemann (2009)
10.1016/J.VACCINE.2005.09.049
Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
G. Widera (2006)
10.1002/9780470409770
Genomics in Drug Discovery and Development
Dimitri Semizarov (2008)
10.1016/S0169-409X(01)00157-0
Potential and problems of developing transdermal patches for veterinary applications.
J. Riviere (2001)
Veterinary Pharmacology and Therapeutics
L. M. Jones (1965)
10.1016/S0022-2836(05)80360-2
Basic local alignment search tool.
S. Altschul (1990)
10.1126/science.270.5235.467
Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
M. Schena (1995)
10.1046/J.1365-2885.1998.00121.X
Population pharmacokinetics in veterinary medicine: potential use for therapeutic drug monitoring and prediction of tissue residues.
T. Martín-Jiménez (1998)
10.1046/j.1365-2796.2002.00995.x
Cutaneous gene transfer for skin and systemic diseases
P. Khavari (2002)
10.1016/J.TVJL.2003.10.020
Technologies for the control of fat and lean deposition in livestock.
M. Sillence (2004)
10.1080/10937404.2010.483176
Toxicity Testing in the 21st Century: A Vision and a Strategy
D. Krewski (2010)
10.1053/TVJL.2001.0568
Pharmacological treatment in behavioural medicine: the importance of neurochemistry, molecular biology and mechanistic hypotheses.
K. Overall (2001)
10.1016/J.JCONREL.2006.11.009
Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.
F. Verbaan (2007)
10.1002/wnan.24
Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots.
J. Riviere (2009)
10.1007/s11095-006-9217-9
The Evolving Role of Drug Metabolism in Drug Discovery and Development
Lilian G. Yengi (2006)
10.1021/AC0346510
Microfluidic devices for the high-throughput chemical analysis of cells.
M. A. McClain (2003)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar